Prosensa will present a status update on Drisapersen and its follow-on compounds in a patient focused webinar hosted by United Parent Projects Muscular Dystrophy (UPPMD) on Tuesday, March 25 at 1 p.m. ET.
If you have any questions regarding recent Prosensa/drisapersen updates or any other topic related to the company’s Duchenne portfolio that you would like to be addressed during the webinar, you may submit these in advance to CureDuchenne. Questions can be submitted until noon on Monday, March 24 by emailing email@example.com (please put “Prosensa Webinar” as the subject line). Prosensa will try to answer as many questions as possible during the webinar.
Audio Dial-In Information:
- U.S. & Canada: Dial 866.740.1260 and use the Access Code 9449985
- Outside the U.S. and Canada: Lookup your number